logo-loader
viewAvacta Group PLC

Avacta’s CTO to present Affimer data at Biomarkers and Precision Medicine Congress

The biotech company said Dr Matt Johnson would present data showing how the Affimer technology can be used to simplify diagnostics and other immunoassays

Conference speaker
The BPMC gathers over 300 delegates from biotech firms, global pharma companies and academic institutions

Avacta Group Plc’s (LON:AVCT) chief technology officer, Dr Matt Johnson, will present new data for the firm’s Affirmer range of research tools and diagnostics reagents at the Biomarkers and Precision Medicine Congress (BPMC) in San Diego on 12 October.

The biotech company said Johnson would present data showing how the Affimer technology can be used to simplify diagnostics and other immunoassays, as well as showing that immunoassays built using Affimers perform as well as, and better than, equivalent assays built using antibodies.

READ: Avacta rises as it secures licensing deal with New England Biolabs for Affimer technology

Avacta added that Johnson would also speak about a class of Affimers that captures antibodies but only when the antibodies are bound to their own targets, offering a route to improving an important type of diagnostic test to have a more specific and clearer result, the commercial potential of which was “significant”.

The BPMC gathers over 300 delegates from leading biotech companies, global pharma organisations and internationally renowned academic institutions to discuss key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers.

Quick facts: Avacta Group PLC

Price: 16.25 GBX

AIM:AVCT
Market: AIM
Market Cap: £18.88 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Avacta Group PLC named herein, including the promotion by the Company of Avacta Group PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Investor Update: Immotion signs deal with Aspro Parks

Headlines from the Proactive UK newsroom. Immotion (LON:IMMO) is to put one of its virtual reality entertainment pods in Spanish leisure operator Aspro Parks’ Blue Planet Aquarium in Cheshire.  Aspro’s one of the largest European operators of leisure parks and centres with 68 locations...

1 week, 2 days ago

2 min read